In The News
Jeff Stevens Brings Evergreen Financial Expertise to Emerging Psychedelic Health Market
Posted: Apr 7, 2023
Jeff Stevens Of Psyched Wellness On The 5 Things You Need To Create A Highly Successful Career In The Health and Wellness Industry
Posted: Mar 17, 2023
Bringing an Alternative Sleep Supplement into the Wellbeing Space Conversation with CEO Jeff Stevens
Posted: Jan 9, 2023
Psyched Wellness says Choice Companies tie-up will be used as a template for distribution partners
Posted: Nov 9, 2022
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
Posted: Nov 3, 2022
Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
Posted: April 19, 2022
Psyched Wellness Chief Operations Officer David Shisel Speaks with the Market Herald about Self GRAS certification
Posted: Mar 10, 2022
Psyched Wellness says 90-day oral toxicity study of Amanita Muscaria reveals no adverse effects
Posted: Feb 17, 2022
Psychedelic Finance Interviews Matthew Singh , Chief Commercial Office at Psyched Wellness
Posted: Feb 4, 2022
Psyched Wellness partners with Vantage Hemp for manufacturing its AME-1-derived consumer products
Posted: Jan 19, 2022
Chief Operating Office Dave Shisel sat down with Dave Jackson to discuss the partnership with Vantage Hemp Co.
Posted: Jan 19, 2022
Psyched Wellness talks about its path to market for AME-1, its Amanita Muscaria extract
Posted: Dec 17, 2021
Psyched Wellness approved by Health Canada to add Amanita muscaria to Natural Health Products list
Posted: Nov 3, 2021
Psyched Wellness is Turning This Instantly-Recognizable Mushroom Into a Health and Wellness Product
Posted: Oct 28, 2021
Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders
Posted: Sept 21, 2021